Healthcare Services APAC

APAC Pharmacovigilance Services Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC Pharmacovigilance Services Market Industry Trends and Forecast to 2034: Segmented by (Service, Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.07 Bn Placeholder estimate
Estimate 2025 $2.33 Bn 22.2% of the global market
Projected 2034 $6.72 Bn 188.7% Adds $4.39 Bn over 9 forecast years
CAGR 2025–2034 12.5% Faster than 71% of 107 Healthcare Services markets here
Key players 5
  • APAC is 22.24% of the global market.
  • Among regions, the largest is North America at $5.61 Bn.
  • Fastest growing: Africa at 12.7% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.39 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Pharmacovigilance Services Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.07 Bn — —
2025 (base) $2.33 Bn +$258.8 Mn —
2026 (forecast) $2.62 Bn +$291.1 Mn +12.5%
2027 (forecast) $2.95 Bn +$327.5 Mn +26.6%
2028 (forecast) $3.32 Bn +$368.5 Mn +42.4%
2029 (forecast) $3.73 Bn +$414.5 Mn +60.2%
2030 (forecast) $4.20 Bn +$466.3 Mn +80.2%
2031 (forecast) $4.72 Bn +$524.6 Mn +102.7%
2032 (forecast) $5.31 Bn +$590.2 Mn +128.1%
2033 (forecast) $5.98 Bn +$664.0 Mn +156.6%
2034 (forecast) $6.72 Bn +$747.0 Mn +188.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Pharmacovigilance Services Market Analysis at a glance
Market size, 2025$2.33 Bn placeholder estimate
Forecast, 2034$6.72 Bn placeholder estimate
Growth (CAGR), 2025–203412.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsService, model and end user (see all)
Key playersIQVIA, ArisGlobal, Parexel, Accenture, Cognizant (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Pharmacovigilance Services Market Analysis Executive Summary

Pharmacovigilance services collect and review reports of side effects to keep medicines safe after approval.

Key segments of the pharmacovigilance Services market include service (Case Processing, Signal Detection and Risk Management) and model (Outsourced and In-House Software).

Bar chart: Asia Pacific Pharmacovigilance Services market size, 2024–2034, placeholder estimates. $2.07 Bn in 2024, $2.33 Bn in 2025 and $6.72 Bn in 2034, 12.5% CAGR.
Asia Pacific Pharmacovigilance Services market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Pharmacovigilance Services Market Dynamics

Market Growth Drivers

Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmacovigilance Services market. Many companies now outsource work they used to do in-house.

Opportunity

Advanced therapies, AI-driven operations and expansion in India, China and Southeast Asia give the pharmacovigilance Services market room to grow.

Market Restraints

Capacity shortages, strict quality rules, data security concerns and pricing pressure hold back the pharmacovigilance Services market.

Competitive Landscape for Pharmacovigilance Services Market in APAC

The pharmacovigilance Services market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Pharmacovigilance Services Market in APAC

Pharmacovigilance Services in APAC: payment

How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[1], basic medical insurance (China)⁠[2], the Hospital Authority (Hong Kong)⁠[3], Ayushman Bharat PM-JAY (India)⁠[4], public health insurance (Japan)⁠[5], subsidised public care (Malaysia)⁠[6], Pharmac (New Zealand)⁠[7], PhilHealth (Philippines)⁠[8], MediShield Life (Singapore)⁠[9] and the Universal Coverage Scheme (Thailand)⁠[10].

[1] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

[3] Hospital Authority. Checked 14 Nov 2026.

[4] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[5] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[6] Ministry of Health Malaysia. Checked 14 Nov 2026.

[7] Pharmac. Checked 14 Nov 2026.

[8] PhilHealth. Checked 14 Nov 2026.

[9] CPF Board, MediShield Life. Checked 14 Nov 2026.

[10] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how pharmacovigilance Services services are delivered and paid for in APAC. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Pharmacovigilance Services right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Pharmacovigilance Services in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Pharmacovigilance Services market in Asia Pacific?
Placeholder estimate: about $2.33 Bn in 2025, rising to about $6.72 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Pharmacovigilance Services market in Asia Pacific growing?
Placeholder estimate: about 12.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Pharmacovigilance Services market report cover?
The report splits the market by service (Case Processing, Signal Detection, Risk Management, Literature Monitoring), model (Outsourced, In-House Software) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Pharmacovigilance Services market?
Key players include IQVIA, ArisGlobal, Parexel, Accenture and Cognizant.
What is driving the Pharmacovigilance Services market?
Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmacovigilance Services market. Many companies now outsource work they used to do in-house.
How much research is published on Pharmacovigilance Services?
PubMed lists 7,687 papers on Pharmacovigilance Services added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in APAC

See all

Related on drug development and manufacturing and clinical trials

See the topic